NCT02540967View on ClinicalTrials.gov

Drug Use Investigation of Gadovist.

CompletedOBSERVATIONAL

Enrollment

3,357

Participants

Timeline

Start Date

October 27, 2015

Primary Completion Date

November 2, 2017

Study Completion Date

November 2, 2017

Conditions

Magnetic Resonance ImagingImage Enhancement

Interventions

DRUG

Gadobutrol (Gadavist/Gadovist, BAY86-4875)

Gadovist dosage following summary of product characteristics

Trial Locations (1)

Unknown

Many Locations, Multiple Locations

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY